baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Summit Therapeutics Inc/ US86627T1088 /

14/05/2024 22:00:00	Chg. -0.1150	Volume	Bid12:22:02	Ask12:22:02	High	Low
4.6850USD	-2.40%	1.67 mill. Turnover: 7 mill.	4.7100Bid Size: 100	4.9000Ask Size: 200	5.1200	4.6800

GlobeNewswire 10/05 ProKidney Reports Business Updates and First Quarter 2024 Financial Results

GlobeNewswire 25/03 ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

GlobeNewswire 07/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 28/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 21/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 08/02 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

GlobeNewswire 17/03/2022 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter an...

GlobeNewswire 09/02/2022 Summit Therapeutics Announces Postponement of Its Planned Rights Offering

GlobeNewswire 01/02/2022 Dr. Maky Zanganeh Launches Personal Memoir, the Magic of Normal, to Honor February Cancer Survivor M...

GlobeNewswire 25/01/2022 Summit Therapeutics Announces Rights Offering

GlobeNewswire 10/01/2022 Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ...

GlobeNewswire 05/01/2022 Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conferen...

GlobeNewswire 20/12/2021 Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infecti...

GlobeNewswire 15/11/2021 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and...

GlobeNewswire 04/11/2021 Entasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 03/11/2021 Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Exe...

GlobeNewswire 11/10/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 08/10/2021 Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of...

GlobeNewswire 04/10/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 30/09/2021 Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action...

GlobeNewswire 24/09/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 11/08/2021 Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 11/08/2021 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Si...

GlobeNewswire 11/08/2021 Summit Therapeutics Provides Update on Ri-CoDIFy Trials

GlobeNewswire 14/07/2021 Entasis Therapeutics Expands Executive Leadership Team with the Appointment of Anna Diaz Triola as C...

Summit Therapeutics Inc/ US86627T1088 /

If you wish to receive reply to your feedback, please provide your email address.